These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
222 related articles for article (PubMed ID: 34125353)
1. Improvement in left ventricular ejection fraction after pharmacological up-titration in new-onset heart failure with reduced ejection fraction. Nauta JF; Santema BT; van der Wal MHL; Koops A; Warink-Riemersma J; van Dijk K; Inkelaar F; Prückl S; Suwijn J; van Deursen VM; Meijers WC; Coster J; Westenbrink BD; de Boer RA; Hummel Y; van Melle J; van Veldhuisen DJ; van der Meer P; Voors AA Neth Heart J; 2021 Jul; 29(7-8):383-393. PubMed ID: 34125353 [TBL] [Abstract][Full Text] [Related]
2. Evaluation of a guideline directed medical therapy titration program in patients with heart failure with reduced ejection fraction. Balakumaran K; Patil A; Marsh S; Ingrassia J; Kuo CL; Jacoby DL; Arora S; Soucier R Int J Cardiol Heart Vasc; 2019 Mar; 22():1-5. PubMed ID: 30480083 [TBL] [Abstract][Full Text] [Related]
3. Contemporary Drug Treatment of Chronic Heart Failure With Reduced Ejection Fraction: The CHECK-HF Registry. Brunner-La Rocca HP; Linssen GC; Smeele FJ; van Drimmelen AA; Schaafsma HJ; Westendorp PH; Rademaker PC; van de Kamp HJ; Hoes AW; Brugts JJ; JACC Heart Fail; 2019 Jan; 7(1):13-21. PubMed ID: 30606482 [TBL] [Abstract][Full Text] [Related]
8. Effects of combined renin-angiotensin-aldosterone system inhibitor and beta-blocker treatment on outcomes in heart failure with reduced ejection fraction: insights from BIOSTAT-CHF and ASIAN-HF registries. Ouwerkerk W; Teng TK; Tromp J; Tay WT; Cleland JG; van Veldhuisen DJ; Dickstein K; Ng LL; Lang CC; Anker SD; Zannad F; Hung CL; Sawhney JPS; Naik A; Shimizu W; Hagiwara N; Wander GS; Anand I; Richards AM; Voors AA; Lam CSP Eur J Heart Fail; 2020 Aug; 22(8):1472-1482. PubMed ID: 32583922 [TBL] [Abstract][Full Text] [Related]
9. Use of Guideline-Directed Medical Therapy in Patients Aged 80 Years or Older With Heart Failure With Reduced Ejection Fraction. Barry AR; Grewal M; Blain L CJC Open; 2023 Apr; 5(4):303-309. PubMed ID: 37124968 [TBL] [Abstract][Full Text] [Related]
10. Right ventricular dysfunction in patients with new-onset heart failure: longitudinal follow-up during guideline-directed medical therapy. Ansari Ramandi MM; van Melle JP; Gorter TM; Hoendermis ES; van Veldhuisen DJ; Nauta JF; van der Wal MHL; Warink-Riemersma J; Voors AA; Dickinson MG Eur J Heart Fail; 2022 Dec; 24(12):2226-2234. PubMed ID: 36250250 [TBL] [Abstract][Full Text] [Related]
13. Characteristics, Outcomes, and Treatment of Heart Failure With Improved Ejection Fraction. Park CS; Park JJ; Mebazaa A; Oh IY; Park HA; Cho HJ; Lee HY; Kim KH; Yoo BS; Kang SM; Baek SH; Jeon ES; Kim JJ; Cho MC; Chae SC; Oh BH; Choi DJ J Am Heart Assoc; 2019 Mar; 8(6):e011077. PubMed ID: 30845873 [TBL] [Abstract][Full Text] [Related]
14. Utilization of guideline-directed medical therapy in patients with de novo heart failure with reduced ejection fraction: A Veterans Affairs study. Khattab M; Parwani P; Abbas M; Ali H; Lozano PM; Thadani U; Dasari TW J Family Med Prim Care; 2020 Jun; 9(6):3065-3069. PubMed ID: 32984174 [TBL] [Abstract][Full Text] [Related]
15. Integration of clinical pharmacists into a heart failure clinic within a safety-net hospital. Shah SP; Dixit NM; Mendoza K; Entabi R; Meymandi S; Balady-Bouziane N; Chan P J Am Pharm Assoc (2003); 2022; 62(2):575-579.e2. PubMed ID: 34896014 [TBL] [Abstract][Full Text] [Related]
16. Association between up-titration of medical therapy and total hospitalizations and mortality in patients with recent worsening heart failure across the ejection fraction spectrum. Bistola V; Simitsis P; Parissis J; Ouwerkerk W; van Veldhuisen DJ; Cleland JG; Anker SD; Samani NJ; Metra M; Zannad F; Polyzogopoulou E; Keramida K; Farmakis D; Voors AA; Filippatos G Eur J Heart Fail; 2021 Jul; 23(7):1170-1181. PubMed ID: 33998113 [TBL] [Abstract][Full Text] [Related]
17. Evaluating Guideline Directed Medical Therapy in Patients With Heart Failure With Reduced Ejection Fraction Post-coronary Artery Bypass Grafting. Kabulski GM; Boughner T; Szymanski TW; Sokos GG; Kido K J Pharm Pract; 2023 Dec; 36(6):1370-1374. PubMed ID: 35926866 [No Abstract] [Full Text] [Related]
18. Identifying optimal doses of heart failure medications in men compared with women: a prospective, observational, cohort study. Santema BT; Ouwerkerk W; Tromp J; Sama IE; Ravera A; Regitz-Zagrosek V; Hillege H; Samani NJ; Zannad F; Dickstein K; Lang CC; Cleland JG; Ter Maaten JM; Metra M; Anker SD; van der Harst P; Ng LL; van der Meer P; van Veldhuisen DJ; Meyer S; Lam CSP; ; Voors AA Lancet; 2019 Oct; 394(10205):1254-1263. PubMed ID: 31447116 [TBL] [Abstract][Full Text] [Related]
19. Uptitration of renin-angiotensin system blocker and beta-blocker therapy in patients hospitalized for heart failure with reduced versus preserved left ventricular ejection fractions. Verbrugge FH; Duchenne J; Bertrand PB; Dupont M; Tang WH; Mullens W Am J Cardiol; 2013 Dec; 112(12):1913-20. PubMed ID: 24286620 [TBL] [Abstract][Full Text] [Related]